Nonalcoholic fatty liver disease (NAFLD) is the leading chronic liver disease worldwide. Its
more advanced subtype, nonalcoholic steatohepatitis (NASH), connotes progressive liver …

Cardiovascular disease (CVD) is still the leading cause of death globally, and
atherosclerosis is the main pathological basis of CVDs. Low-density lipoprotein cholesterol …

How amphipathic phospholipids are shuttled between the membrane bilayer remains an
essential but elusive process, particularly at the endoplasmic reticulum (ER). One prominent …

Aging is a complex process indicated by low energy levels, declined physiological activity,
stress induced loss of homeostasis leading to the risk of diseases and mortality. Recent …

Sphingomyelin (SM) is a widely occurring sphingolipid that is a major plasma membrane
constituent. Milk and dairy products are rich SM sources, and human milk has high SM …

Pemafibrate (PEM) is a novel lipid-lowering drug classified as a selective peroxisome
proliferator-activated receptor α (PPARα) modulator whose binding efficiency to PPARα is …

Non-alcoholic fatty liver disease (NAFLD) and atherosclerosis (ATS) are worldwide known
diseases with increased incidence and prevalence. These two are driven and are …

Compelling evidence supports the causative link between increased levels of low-density
lipoprotein cholesterol (LDL-C) and atherosclerotic cardiovascular disease (CVD) …

Sex-linked dwarf (SLD) chicken, which is caused by a recessive mutation of the growth
hormone receptor (GHR), has been widely used in the Chinese broiler industry. However, it …

Silicon included in a restructured meat (RM) matrix (Si-RM) as a functional ingredient has
been demonstrated to be a potential bioactive antidiabetic compound. However, the jejunal …